Lockheed Martin Corporation vs Tilray Brands Inc — how do they compare? Lockheed Martin Corporation trades at $504.9 (market cap $117.48B), while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: Lockheed Martin Corporation is far larger — about 224.2× Tilray Brands Inc's market cap, and Lockheed Martin Corporation pays a 2.71% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| LMT | TLRY | |
|---|---|---|
Market Cap | $117.48B | $524.07M |
Sector | Industrials | Health |
52-Week High | $676.70 | $21.00 |
52-Week Low | $410.74 | $4.23 |
Enterprise Value | $136.28B | $621.22M |
Dividend Yield | 2.71% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
Trailing returns across standard periods
Latest headlines on both assets
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →